CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tasly Pharmaceutical Group Company Limited Company Snapshot
Tasly Pharmaceutical Group Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tasly Pharmaceutical Group Company Limited with three other companies in this sector in CHINA : Sichuan Kelun Pharmaceutical Company Limited (2019 sales of 17.64 billion Chinese Renmimbi [US$2.68 billion] of which 98% was Medical and Pharmaceutical Products), Jiangsu Hengrui Medicine Co Ltd (23.29 billion Chinese Renmimbi [US$3.54 billion] of which 100% was Medicinal Manufacturing), and Humanwell Healthcare Group Co Ltd (21.81 billion Chinese Renmimbi [US$3.32 billion] of which 90% was Medication & Health Products).

Sales Analysis. Tasly Pharmaceutical Group Company Limited reported sales of 19.00 billion Chinese Renmimbi (US$2.89 billion) for the year ending December of 2019. This represents an increase of 5.6% versus 2018, when the company's sales were 17.99 billion Chinese Renmimbi. Sales at Tasly Pharmaceutical Group Company Limited have increased during each of the previous five years (and since 2014, sales have increased a total of 51%). Sales of Medicine Commerce saw an increase that was more than double the company's growth rate: sales were up 18.0% in 2019, from 10.78 billion Chinese Renmimbi to 12.72 billion Chinese Renmimbi. Not all segments of Tasly Pharmaceutical Group Company Limited experienced an increase in sales in 2019: sales of Other fell 22.1% to 65.83 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Tasly Pharmaceutical Group Company Limited also experienced decreases in sales in Pharmaceutical and Medicine Manufacturing (down 12.8% to 6.22 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tasly Pharmaceutical Group Company Limited
  Stock Performance Chart for Tasly Pharmaceutical Group Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/27/2020): 16.76
(Figures in Chinese Renmimbi)
1 Week -4.2%   13 Weeks -4.2%  
4 Weeks -6.0%   52 Weeks 9.8%  
 
Tasly Pharmaceutical Group Company Limited Key Data:
  Ticker: 600535 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 18,998,310,343
(Year Ending Jan 2020).
Employees: 9,235
  Currency: Chinese Renmimbi Market Cap: 25,352,285,998
  Fiscal Yr Ends: December Shares Outstanding: 1,512,666,229
  Share Type: A Gu Closely Held Shares: 739,980,136
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.